Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
PURE Bioscience (PURE) had Non-Operating Income/Expense of $-0.07M for the most recently reported fiscal quarter, ending 2025-01-31.
| Income Statement Financials | |
$0.39M |
|
$-0.80M |
|
$0.16M |
|
$0.23M |
|
$1.12M |
|
$-0.72M |
|
|
Non-Operating Income/Expense |
$-0.07M |
$-0.80M |
|
$-0.80M |
|
$-0.80M |
|
$-0.80M |
|
$-0.80M |
|
$-0.80M |
|
$-0.72M |
|
$-0.72M |
|
111.86M |
|
111.86M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.56M |
|
$0.01M |
|
$0.01M |
|
$0.57M |
|
$0.87M |
|
$3.98M |
|
$3.98M |
|
$4.84M |
|
$-4.27M |
|
$-4.27M |
|
$-4.27M |
|
111.86M |
|
| Cash Flow Statement Financials | |
$-1.05M |
|
-- |
|
$0.90M |
|
$0.42M |
|
$0.28M |
|
$-0.15M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.65 |
|
-- |
|
-- |
|
-13.61 |
|
-0.93 |
|
58.06% |
|
-185.42% |
|
-185.42% |
|
-- |
|
-204.09% |
|
-204.09% |
|
$-1.05M |
|
-- |
|
-- |
|
-- |
|
0.68 |
|
2.19 |
|
2.17 |
|
41.43 |
|
18.70% |
|
18.70% |
|
-139.02% |
|
273.29% |
|
$-0.04 |
|
$-0.01 |
|
$-0.01 |
|